SCHEMBL26001031

SCHEMBL26001031

COCCOCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18233782 0.89
SCHEMBL402381 0.89
SCHEMBL10301170 0.89
SCHEMBL17281251 0.89
SCHEMBL10301167 0.89
SCHEMBL10301174 0.89
SCHEMBL13397724 0.88
SCHEMBL18233783 0.84 EPHX2 (0.31)
SCHEMBL18233787 0.84 EPHX2 (0.31)
SCHEMBL26453030 0.84 EPHX2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230398207-A1 MODULATING TH1/TH2 IMMUNE RESPONSE BY ADMINISTERING TWO POPULATIONS OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN AND AN ASSOCIATED ADJUVANT ACM BIOLABS PTE LTD (SG) 2023-12-14 US disclosed
US-20230256082-A1 VACCINE AGAINST HUMAN-PATHOGENIC CORONAVIRUSES ACM BIOLABS PTE LTD (SG) 2023-08-17 US disclosed